Lv7
4060 积分 2023-05-24 加入
Deucravacitinib in Moderate to Severe Plaque Psoriasis: Comorbidities and Use of Prior and Concomitant Medication in Patients Enrolled in the Phase 3 POETYK PSO-1 and PSO-2 Trials
4天前
已完结
First PROTAC gains FDA approval, bolstering targeted protein degradation and induced proximity ambitions
14天前
已完结
Safety considerations for cereblon-recruiting targeted protein degraders
1个月前
已完结
Efficacy and safety of topical brepocitinib cream for mild-to-moderate chronic plaque psoriasis: a phase IIb randomized double-blind vehicle-controlled parallel-group study
3个月前
已完结
Efficacy and Safety of Obinutuzumab in Active Systemic Lupus Erythematosus
3个月前
已完结
From Convenience to Clinical Efficacy: Selective TYK2 Inhibition in Psoriasis and the Evolving Role of Next-Generation Oral Targeted Therapies
3个月前
已完结
Development and validation of a histological index for UC
4个月前
已完结
Tocilizumab Monotherapy or Combined With Methotrexate for Rheumatoid Arthritis
4个月前
已完结
Mycophenolate Mofetil and New-Onset Systemic Lupus Erythematosus
4个月前
已完结
Add-On Treatment With Zilebesiran for Inadequately Controlled Hypertension
4个月前
已完结
皖公网安备34019202002308
